Tetraspanin CD63 acts as a pro-metastatic factor via β-catenin stabilization (Q38944125)

7 September 2017

title

Tetraspanin CD63 acts as a pro-metastatic factor via β-catenin stabilization (English)

1 reference

7 September 2017

8

1 reference

7 September 2017

7

Mathias Heikenwalder

0 references

Haissi Cui

object named as

Haissi Cui

2

0 references

author name string

Bastian Seubert

1

1 reference

7 September 2017

Nicole Simonavicius

3

1 reference

7 September 2017

Katja Honert

4

1 reference

7 September 2017

Sandra Schäfer

5

1 reference

7 September 2017

Ute Reuning

6

1 reference

7 September 2017

Achim Krüger

9

1 reference

7 September 2017

language of work or name

English

0 references

publication date

11 November 2014

1 reference

International Journal of Cancer

7 September 2017

published in

1 reference

7 September 2017

volume

136

1 reference

7 September 2017

issue

10

1 reference

7 September 2017

page(s)

2304-2315

1 reference

Hallmarks of Cancer: The Next Generation

7 September 2017

cites work

1 reference

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

Epithelial-mesenchymal transitions in development and disease

21 January 2018

1 reference

The basics of epithelial-mesenchymal transition

21 January 2018

1 reference

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

21 January 2018

1 reference

beta-catenin destruction complex: insights and questions from a structural perspective

21 January 2018

1 reference

Tetraspanins: push and pull in suppressing and promoting metastasis

21 January 2018

1 reference

Tetraspanin functions and associated microdomains

21 January 2018

1 reference

Protein-protein interactions in the tetraspanin web.

21 January 2018

1 reference

Proteomic analysis of the tetraspanin web using LC-ESI-MS/MS and MALDI-FTICR-MS.

21 January 2018

1 reference

Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation

21 January 2018

1 reference

TIMP-4 and CD63: new prognostic biomarkers in human astrocytomas

21 January 2018

1 reference

High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients

21 January 2018

1 reference

Trafficking and function of the tetraspanin CD63.

21 January 2018

1 reference

Suppression of human melanoma cell growth and metastasis by the melanoma‐associated antigen CD63 (ME491)

21 January 2018

1 reference

CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with beta 1 integrins in human melanoma

21 January 2018

1 reference

A decrease in the expression of CD63 tetraspanin protein elevates invasive potential of human melanoma cells

21 January 2018

1 reference

CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung

21 January 2018

1 reference

Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein

21 January 2018

1 reference

Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation

21 January 2018

1 reference

TIMP-1 induces an EMT-like phenotypic conversion in MDCK cells independent of its MMP-inhibitory domain

21 January 2018

1 reference

Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt/β-catenin signaling

21 January 2018

1 reference

Full-length L1CAM and not its Δ2Δ27 splice variant promotes metastasis through induction of gelatinase expression

21 January 2018

1 reference

A disintegrin and metalloproteinase-10 (ADAM-10) mediates DN30 antibody-induced shedding of the met surface receptor

21 January 2018

1 reference

Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors

21 January 2018

1 reference

Systematic optimization of multiplex zymography protocol to detect active cathepsins K, L, S, and V in healthy and diseased tissue: compromise among limits of detection, reduced time, and resources

21 January 2018

1 reference

Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling

21 January 2018

1 reference

Differential role of beta-catenin in VEGF and histamine-induced MMP-2 production in microvascular endothelial cells

21 January 2018

1 reference

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

TGF-beta and epithelial-to-mesenchymal transitions

21 January 2018

1 reference

Functional genetic mouse models: promising tools for investigation of the proteolytic internet

21 January 2018

1 reference

Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis

21 January 2018

1 reference

Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

21 January 2018

1 reference

Dissemination and growth of cancer cells in metastatic sites

21 January 2018

1 reference

Metastasis: from dissemination to organ-specific colonization

21 January 2018

1 reference

Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer

21 January 2018

1 reference

CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells

21 January 2018

1 reference

Role of adaptor complex AP-3 in targeting wild-type and mutated CD63 to lysosomes

21 January 2018

1 reference

CXCR4 expression on activated B cells is downregulated by CD63 and IL-21.

21 January 2018

1 reference

The role of tetraspanin CD63 in antigen presentation via MHC class II.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29296

1 reference

7 September 2017

1 reference